Translations:Zinc and the common cold/1/ja: Difference between revisions

Revision as of 20:03, 18 April 2024

Information about message (contribute)

This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.

Message definition (Zinc and the common cold)

{{short description|Overview of the relationship between Zinc and the common cold}}
<noinclude>
[[File:Zinc 50 mg.jpg|thumb|182px|Zinc gluconate 50 mg tablets ([[General Nutrition Centers|GNC]] brand)]]
</noinclude>
{{If pagename|Zinc and the common cold='''Zinc supplements'''|other=Zinc supplements}} (frequently [[zinc acetate]] or [[zinc gluconate]] [[Throat lozenge|lozenge]]s) are a group of [[dietary supplements]] that are commonly used for the treatment of the {{no selflink|common cold}}. The use of zinc supplements at doses in excess of 75 mg/day within 24 hours of the onset of symptoms has been shown to reduce the duration of cold symptoms by about 1 day in adults. Adverse effects with zinc supplements [[Oral administration|by mouth]] include bad taste and [[nausea]]. The [[Nasal administration|intranasal use]] of zinc-containing [[nasal spray]]s has been associated with the [[anosmia|loss of the sense of smell]]; consequently, in June 2009, the [[United States Food and Drug Administration]] (USFDA) warned consumers to stop using intranasal zinc.

Zinc supplements （酢酸亜鉛やグルコン酸亜鉛が多い）ロゼンジは、common cold/jaの治療に一般的に使用される一群の栄養補助食品である。症状の発現から24時間以内に75 mg/日を超える用量の亜鉛サプリメントを使用すると、成人では風邪症状の持続期間が約1 日短縮することが示されている。亜鉛サプリメントの口から副作用には、悪味と吐き気がある。亜鉛を含む点鼻薬の経鼻使用は、嗅覚の喪失と関連している；その結果、2009年6月、米国食品医薬品局（USFDA）は、経鼻亜鉛の使用を中止するよう消費者に警告した。

Translations:Zinc and the common cold/1/ja: Difference between revisions

Revision as of 20:03, 18 April 2024

Navigation menu

Search